{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T05:49:06Z","timestamp":1785304146278,"version":"3.55.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.hfc.2026.02.002","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:58:36Z","timestamp":1781711916000},"page":"261-272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pulmonary Hypertension"],"prefix":"10.1016","volume":"22","author":[{"given":"Ermanno","family":"Nardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Maria","family":"Abbellito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Marzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Gargiulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Perrone-Filardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Paolillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hfc.2026.02.002_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccm.2015.02.007","article-title":"Pulmonary vascular diseases","author":"Cummings","year":"2015","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.hfc.2026.02.002_bib2","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00879-2022","article-title":"ESC\/ERS scientific document group. 2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","author":"Humbert","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hfc.2026.02.002_bib3","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.15.04098","article-title":"Global distribution of prognostically significant pulmonary pressure indicative of pulmonary hypertension","author":"Strange","year":"2025","journal-title":"J Glob Health"},{"key":"10.1016\/j.hfc.2026.02.002_bib4","article-title":"A global view of pulmonary hypertension","author":"Hoeper","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.hfc.2026.02.002_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.104.503540","article-title":"Pulmonary arterial hypertension","author":"McLaughlin","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2026.02.002_bib6","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-024-03235-y","article-title":"Mortality from pulmonary hypertension in Europe 2001-2019","author":"Hartley","year":"2024","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.hfc.2026.02.002_bib7","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01887-2018","article-title":"Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives","author":"Humbert","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hfc.2026.02.002_bib8","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01095-2024","article-title":"Pathology and pathobiology of pulmonary hypertension: current insights and future directions","author":"Guignabert","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hfc.2026.02.002_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.113.004555","article-title":"Immune dysregulation and endothelial dysfunction in pulmonary arterial hypertension: a complex interplay","author":"Huertas","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2026.02.002_bib10","article-title":"Pulmonary hypertension","author":"Mocumbi","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.hfc.2026.02.002_bib11","series-title":"StatPearls","article-title":"Pulmonary hypertension","author":"Manek","year":"2024"},{"key":"10.1016\/j.hfc.2026.02.002_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvz308","article-title":"Chronic inflammation within the vascular wall in pulmonary arterial hypertension: more than a spectator","author":"Huertas","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hfc.2026.02.002_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.113.301141","article-title":"Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension","author":"Rabinovitch","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.hfc.2026.02.002_bib14","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201201-0164OC","article-title":"Modern age pathology of pulmonary arterial hypertension","author":"Stacher","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hfc.2026.02.002_bib15","doi-asserted-by":"crossref","DOI":"10.1186\/s12881-017-0440-5","article-title":"A systematic review of genetic mutations in pulmonary arterial hypertension","author":"Garcia-Rivas","year":"2017","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.hfc.2026.02.002_bib16","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.111.060269","article-title":"MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach","author":"Parikh","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2026.02.002_bib17","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20101812","article-title":"Role for miR-204 in human pulmonary arterial hypertension","author":"Courboulin","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.hfc.2026.02.002_bib18","doi-asserted-by":"crossref","DOI":"10.1165\/rcmb.2014-0166TR","article-title":"MicroRNAs in pulmonary arterial hypertension","author":"Zhou","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.hfc.2026.02.002_bib19","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20160745","article-title":"Complications of pulmonary hypertension: a pictorial review","author":"Mak","year":"2017","journal-title":"Br J Radiol"},{"key":"10.1016\/j.hfc.2026.02.002_bib20","doi-asserted-by":"crossref","DOI":"10.1183\/09031936.00046612","article-title":"Pathobiology of pulmonary arterial hypertension and right ventricular failure","author":"Voelkel","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hfc.2026.02.002_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168706","article-title":"Use of ECG and other simple non-invasive tools to assess pulmonary hypertension","author":"Kovacs","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.hfc.2026.02.002_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41569-020-0381-0","article-title":"Cardiac natriuretic peptides","author":"Goetze","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.hfc.2026.02.002_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/crj.12991","article-title":"Serum cardiac troponin elevation predicts mortality in patients with pulmonary hypertension: a meta-analysis of eight cohort studies","author":"Xu","year":"2019","journal-title":"Clin Res J"},{"key":"10.1016\/j.hfc.2026.02.002_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2026.02.002_bib25","author":"Galderisi","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2026.02.002_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/S0735-1097(02)02964-9","article-title":"Pulmonary function in primary pulmonary hypertension","author":"Sun","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2026.02.002_bib27","article-title":"Diagnostic accuracy of computed tomography for chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis","author":"Dong","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.hfc.2026.02.002_bib28","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.106.039438","article-title":"Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension","author":"Tunariu","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.hfc.2026.02.002_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2015.10.023","article-title":"The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update","author":"Mehra","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.hfc.2026.02.002_bib30","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007981","article-title":"Role of pulmonary artery wedge pressure saturation during right heart catheterization: a prospective study","author":"Viray","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hfc.2026.02.002_bib31","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.104.488486","article-title":"Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension","author":"Sitbon","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2026.02.002_bib32","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM199207093270203","article-title":"The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension","author":"Rich","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2026.02.002_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2016.08.1439","article-title":"Clinical relevance of fluid challenge in patients evaluated for pulmonary hypertension","author":"D'Alto","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.hfc.2026.02.002_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/ehjci\/jeaa001","article-title":"A machine learning cardiac magnetic resonance approach to extract disease features and automate pulmonary arterial hypertension diagnosis","author":"Swift","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2026.02.002_bib35","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01899-2018","article-title":"Genetics and genomics of pulmonary arterial hypertension","author":"Morrell","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hfc.2026.02.002_bib36","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaa696","article-title":"Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial","author":"Gr\u00fcnig","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2026.02.002_bib37","article-title":"ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension","author":"Gr\u00fcnig","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hfc.2026.02.002_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203396","article-title":"The crucial impact of iron deficiency definition for the course of precapillary pulmonary hypertension","author":"Sonnweber","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.hfc.2026.02.002_bib39","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/suz207","article-title":"The practical management of fluid retention in adults with right heart failure due to pulmonary arterial hypertension","author":"Stickel","year":"2019","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.hfc.2026.02.002_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2020.08.024","article-title":"Can anticoagulants improve the survival rate for patients with idiopathic pulmonary arterial hypertension? A systematic review and meta-analysis","author":"Wang","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.hfc.2026.02.002_bib41","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202004-1006OC","article-title":"Risk reduction and hemodynamics with initial combination therapy in pulmonary arterial hypertension","author":"Badagliacca","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hfc.2026.02.002_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2021.07.057","article-title":"Three- versus two-drug therapy for patients with newly diagnosed pulmonary arterial hypertension","author":"Chin","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2026.02.002_bib43","doi-asserted-by":"crossref","DOI":"10.1183\/09031936.00184412","article-title":"Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses","author":"Trip","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hfc.2026.02.002_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2019.09.010","article-title":"Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: results from the AMBITION trial","author":"McLaughlin","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.hfc.2026.02.002_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2019.09.009","article-title":"Risk reduction and right heart reverse remodeling by upfront triple combination therapy in pulmonary arterial hypertension","author":"D'Alto","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.hfc.2026.02.002_bib46","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","author":"Ghofrani","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2026.02.002_bib47","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2213558","article-title":"Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension","author":"Hoeper","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2026.02.002_bib48","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2415160","article-title":"Sotatercept in patients with pulmonary arterial hypertension at high risk for death","author":"Humbert","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2026.02.002_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2023.10.045","article-title":"Randomized trial of macitentan\/tadalafil single-tablet combination therapy for pulmonary arterial hypertension","author":"Gr\u00fcnig","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2026.02.002_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.12119","article-title":"INSPIRE: safety and tolerability of inhaled yutrepia (treprostinil) in pulmonary arterial hypertension (PAH)","author":"Hill","year":"2022","journal-title":"Pulm Circ"},{"key":"10.1016\/j.hfc.2026.02.002_bib51","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01897-2018","article-title":"Pulmonary hypertension due to left heart disease","author":"Vachi\u00e9ry","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hfc.2026.02.002_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(19)30250-4","article-title":"Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study","author":"Nathan","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10.1016\/j.hfc.2026.02.002_bib53","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJMoa2008470","article-title":"Inhaled treprostinil in pulmonary hypertension due to interstitial lung disease","volume":"384","author":"Waxman","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2026.02.002_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2022.02.002","article-title":"Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension","author":"Humbert","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.hfc.2026.02.002_bib55","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01915-2018","article-title":"Chronic thromboembolic pulmonary hypertension","author":"Kim","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hfc.2026.02.002_bib56","article-title":"Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic disease","author":"Wiedenroth","year":"2018","journal-title":"Pulm Circ"},{"key":"10.1016\/j.hfc.2026.02.002_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(22)00214-4","article-title":"Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study","author":"Ja\u00efs","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.hfc.2026.02.002_bib58","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.mayocp.2023.05.006","article-title":"Machine learning for diagnosis of pulmonary hypertension by echocardiography","volume":"99","author":"Anand","year":"2024","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.hfc.2026.02.002_bib59","article-title":"AI-Enabled accurate non-invasive assessment of pulmonary hypertension progression via multi-modal echocardiography","author":"Yang","year":"2025","journal-title":"arXiv"},{"key":"10.1016\/j.hfc.2026.02.002_bib60","article-title":"Development and validation of multimodal deep learning algorithms for detecting pulmonary hypertension","author":"Zhao","year":"2025","journal-title":"npj Digit Med"},{"key":"10.1016\/j.hfc.2026.02.002_bib61","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00229-2023","article-title":"Machine learning to differentiate pulmonary hypertension due to left heart disease from pulmonary arterial hypertension","author":"Swinnen","year":"2023","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.hfc.2026.02.002_bib62","doi-asserted-by":"crossref","DOI":"10.1093\/ehjimp\/qyad014","article-title":"Non-invasive estimation of mean pulmonary artery pressure by cardiovascular magnetic resonance in under 2 min scan time","author":"Abdula","year":"2023","journal-title":"Eur Heart J Imaging Methods Pract"},{"issue":"5","key":"10.1016\/j.hfc.2026.02.002_bib63","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3390\/biom14050552","article-title":"Circulating biomarkers in pulmonary arterial hypertension: an update","volume":"14","author":"Correale","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.hfc.2026.02.002_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.12063","article-title":"BREEZE: Open-label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI\u2122 in patients with pulmonary arterial hypertension","author":"Spikes","year":"2022","journal-title":"Pulm Circ"},{"key":"10.1016\/j.hfc.2026.02.002_bib66","doi-asserted-by":"crossref","DOI":"10.1177\/2045894019878615","article-title":"Long-term results of the DelIVery for pulmonary arterial hypertension trial","author":"Gomberg-Maitland","year":"2019","journal-title":"Pulm Circ"},{"key":"10.1016\/j.hfc.2026.02.002_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(24)00072-9","article-title":"Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial","author":"Frantz","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.hfc.2026.02.002_bib68","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01110-2024","article-title":"MK-5475, an inhaled soluble guanylate cyclase stimulator, for treatment of pulmonary arterial hypertension: the INSIGNIA-PAH study","author":"Humbert","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hfc.2026.02.002_bib69","doi-asserted-by":"crossref","DOI":"10.1007\/s40268-024-00453-x","article-title":"Future perspectives of pulmonary arterial hypertension: a review of novel pipeline treatments and indications","author":"Novara","year":"2024","journal-title":"Drugs R&D"},{"key":"10.1016\/j.hfc.2026.02.002_bib73","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.12251","article-title":"SATISFY-JP, a phase II multicenter open-label study on satralizumab, an anti-IL-6 receptor antibody, use for the treatment of pulmonary arterial hypertension in patients with an immune-responsive-phenotype: study protocol","author":"Tamura","year":"2023","journal-title":"Pulm Circ"},{"key":"10.1016\/j.hfc.2026.02.002_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/biom12040496","article-title":"MicroRNAs in pulmonary hypertension, from pathogenesis to diagnosis and treatment","author":"Xu","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.hfc.2026.02.002_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.jjcc.2019.04.006","article-title":"Mesenchymal stem\/stromal cell therapy for pulmonary arterial hypertension: comprehensive review of preclinical studies","author":"Fukumitsu","year":"2019","journal-title":"J Cardiol"},{"key":"10.1016\/j.hfc.2026.02.002_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2025.133078","article-title":"Pulmonary artery denervation in pulmonary hypertension: a comprehensive meta-analysis","author":"Abouzid","year":"2025","journal-title":"Int J Cardiol"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713626000139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713626000139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:59:09Z","timestamp":1781711949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713626000139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1551713626000139"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2026.02.002","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary Hypertension","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2026.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}